Skip to main content

Table 1 Basic patient characteristics

From: The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study

 

DMSO-containing (protocol 1)

DMSO-free (protocol 2)

P-value

Age (years)

22.6 (19.1;32.1)

21.9 (18.9;29.0)

0.716

BMI (kg/m2)

23.2 (21.8;26.2)

23.9 (21.1;24.8)

0.780

FSH (mU/ml)

3.1 (1.8;5.7)

6.5 (3.6;7.3)

0.195

LH (mU/ml)

1.5 (0.5;5.5)

3.5 (1.0;8.7)

0.780

Estradiol (pg/ml)

39 (36;52)

39 (22;42)

0.173

Testosterone (ng/ml)

5.6 (3.2;7.6)

4.9 (4.3;6.1)

0.701

SHBG (nmol/l)

25.2 (21.7;38.2)

28.0 (21.0;46.1)

0.652

Treatment duration (months)

17 (15;33)

17 (11;18)

0.183

  1. Values are provided as median and interquartile ranges
  2. BMI Body mass index, FSH Follicle stimulating hormone, LH Luteinizing hormone, SHBG Sexual hormone binding globulin, treatment duration Duration of androgen treatment (months)